MARRA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 371
EU - Europa 265
AS - Asia 208
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 848
Nazione #
US - Stati Uniti d'America 370
IT - Italia 105
IE - Irlanda 80
SG - Singapore 76
HK - Hong Kong 54
CN - Cina 32
VN - Vietnam 28
SE - Svezia 15
DE - Germania 14
KR - Corea 13
FI - Finlandia 11
RU - Federazione Russa 9
RO - Romania 7
UA - Ucraina 6
CZ - Repubblica Ceca 5
CH - Svizzera 3
NL - Olanda 3
AT - Austria 2
FR - Francia 2
GR - Grecia 2
IN - India 2
JP - Giappone 2
AZ - Azerbaigian 1
BO - Bolivia 1
BR - Brasile 1
CA - Canada 1
EU - Europa 1
GB - Regno Unito 1
NZ - Nuova Zelanda 1
Totale 848
Città #
Chandler 95
Dublin 78
Singapore 62
Hong Kong 54
Perugia 51
Boardman 39
San Mateo 35
Dong Ket 28
Santa Clara 27
Seoul 13
Altamura 12
Medford 12
Helsinki 11
Lawrence 11
Princeton 11
Bucharest 7
Munich 6
Andover 5
Dallas 5
Falls Church 5
Norwalk 5
Wilmington 5
New York 4
Redmond 4
Rome 4
Ancona 3
Brno 3
Collazzone 3
Des Moines 3
Florence 3
Los Angeles 3
Saint Petersburg 3
San Paolo di Civitate 3
Amsterdam 2
Ashburn 2
Beijing 2
Bengaluru 2
Campobasso 2
Chicago 2
Esslingen am Neckar 2
Fairfield 2
Houston 2
Milan 2
Nanning 2
Olomouc 2
San Diego 2
Santarcangelo di Romagna 2
Thessaloniki 2
Vienna 2
Auckland 1
Baku 1
Baotou 1
Belgioioso 1
Cambridge 1
Clifton 1
Foligno 1
Fremont 1
Fukushima 1
Groningen 1
Guangzhou 1
Jacksonville 1
Jinan 1
La Paz 1
Lausanne 1
London 1
Montréal 1
Newark 1
Nuremberg 1
Paris 1
Rimini 1
Shanghai 1
Shijiazhuang 1
Spello 1
Tampa 1
Tokyo 1
Totale 671
Nome #
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 97
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 73
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 71
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 70
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 62
Richter's transformation in the heart 58
Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysis. 56
Hhv8-positive castleman disease and in situ mantle cell neoplasia within dermatopathic lymphadenitis, in longstanding psoriasis 47
Flower cells of tropical descent: a challenging case of adult T-cell leukemia/lymphoma 46
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 46
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 38
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 37
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 32
Current status and future perspectives in targeted therapy of NPM1-mutated AML 28
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 28
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 28
Collision diffuse large B cell lymphoma and myeloid sarcoma in the liver 22
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 22
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia 19
CD47 expression in acute myeloid leukemia varies according to genotype 13
Starry sky pattern predicts RAS pathway activation in NPM1‐mutated acute myeloid leukemia 7
An unusual form of BRAF‐V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine 6
Totale 906
Categoria #
all - tutte 4.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 8 14 0 0
2020/202143 0 0 0 0 14 0 0 0 0 0 1 28
2021/2022176 17 43 1 3 10 3 5 19 8 9 40 18
2022/2023279 14 42 7 29 24 32 4 8 91 7 14 7
2023/2024184 7 11 10 3 1 3 54 2 11 7 37 38
2024/2025190 21 32 26 20 61 30 0 0 0 0 0 0
Totale 906